z-logo
Premium
A phase II trial of AZD 1152 in relapsed/refractory diffuse large B‐cell lymphoma
Author(s) -
Collins Graham P.,
Eyre Toby A.,
Linton Kim M.,
Radford John,
Vallance Grant D.,
Soilleux Elizabeth,
Hatton Chris
Publication year - 2015
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13333
Subject(s) - medicine , refractory (planetary science) , lymphoma , cytarabine , rituximab , diffuse large b cell lymphoma , aurora b kinase , phases of clinical research , cancer research , oncology , chemotherapy , spindle apparatus , chemistry , cell , biology , astrobiology , biochemistry , cell division

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom